Danielle Rodin

Expanding global access to radiotherapy

Radiotherapy is a critical and inseparable component of comprehensive cancer treatment and care. For many of the most common cancers in low-income and middle-income countries, radiotherapy is essential for effective treatment. In high-income countries, radiotherapy is used in more than half of all cases of cancer to cure localised disease, palliate symptoms, and control disease in incurable cancers. Yet, in planning and building treatment capacity for cancer, radiotherapy is frequently the last resource to be considered. Consequently, worldwide access to radiotherapy is unacceptably low. We present a new body of evidence that quantifies the worldwide coverage of radiotherapy services by country. We show the shortfall in access to radiotherapy by country and globally for 2015-35 based on current and projected need, and show substantial health and economic benefits to investing in radiotherapy. The cost of scaling up radiotherapy in the nominal model in 2015-35 is US

Global cancer surgery: delivering safe, affordable, and timely cancer surgery

26·6 billion in low-income countries,

Commentary: Explaining enormous variations in rates of disorder in trauma-focused psychiatric epidemiology after major emergencies

62·6 billion in lower-middle-income countries, and

A Systematic Review of Radiotherapy Capacity in Low- and Middle-Income Countries

94·8 billion in upper-middle-income countries, which amounts to

Changes in end of life care 5 years after the introduction of a rapid response team: A multicentre retrospective study

184·0 billion across all low-income and middle-income countries. In the efficiency model the costs were lower:

Global Task Force on Radiotherapy for Cancer Control.

14·1 billion in low-income,

Training Global Oncologists: Addressing the Global Cancer Control Problem

33·3 billion in lower-middle-income, and

Educational inequalities in blood pressure and cholesterol screening in nine European countries

49·4 billion in upper-middle-income countries-a total of

Language dominance in children with epilepsy: Concordance of fMRI with intracarotid amytal testing and cortical stimulation

96·8 billion. Scale-up of radiotherapy capacity in 2015-35 from current levels could lead to saving of 26·9 million life-years in low-income and middle-income countries over the lifetime of the patients who received treatment. The economic benefits of investment in radiotherapy are very substantial. Using the nominal cost model could produce a net benefit of

Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience

278·1 billion in 2015-35 (